Abstract:A comprehensive investigation of the Hg 2+ coordination chemistry and 197m/g Hg radiolabeling capabilities of cyclen-based commercial chelators, namely, DOTA and DOTAM (aka TCMC), along with their bifunctional counterparts, p -SCN-Bn-DOTA and p -SCN-Bn-TCMC, was conducted to assess the suitability of these frameworks as bifunctional chelators for the 197m/g Hg 2+ theranostic pair. Radiolabeling studies revealed that TCMC and DOTA exhibited low radiochemical yields (0%–6%), even when subjected to harsh conditions (80°C) and high ligand concentrations (10 –4 M). In contrast, p -SCN-Bn-TCMC and p -SCN-Bn-DOTA demonstrated significantly higher 197m/g Hg radiochemical yields (100% ± 0.0% and 70.9% ± 1.1%, respectively) under the same conditions. The [ 197 m/g Hg]Hg- p -SCN-Bn-TCMC complex was kinetically inert when challenged against human serum and glutathione. To understand the differences in labeling between the commercial chelators and their bifunctional counterparts, non-radioactive nat Hg 2+ complexes were assessed using NMR spectroscopy and DFT calculations. The NMR spectra of Hg-TCMC and Hg- p -SCN-Bn-TCMC suggested binding of the Hg 2+ ion through the cyclen backbone framework. DFT studies indicated that binding of the Hg 2+ ion within the backbone forms a thermodynamically stable product. However, competition can form between isothiocyanate binding and binding through the macrocycle, which was experimentally observed. The isothiocyanate bound coordination product was dominant at the radiochemical scale as, in comparison, the macrocycle bound product was seen at the NMR scale, agreeing with the DFT result. Furthermore, a bioconjugate of TCMC (TCMC-PSMA) targeting prostate-specific membrane antigen was synthesized and radiolabeled, resulting in an apparent molar activity of 0.089 MBq/nmol. However, the complex demonstrated significant degradation over 24 h when exposed to human serum and glutathione. Subsequently, cell binding assays were conducted, revealing a K i value ranging from 19.0 to 19.6 nM. This research provides crucial insight into the effectiveness of current commercial chelators in the context of 197m/g Hg 2+ radiolabeling. It underscores the necessity for the development of specific and customized chelators to these unique "soft" radiometals to advance 197m/g Hg 2+ radiopharmaceuticals.

Diphosphine Bioconjugates via Pt(0)-Catalyzed Hydrophosphination. A Versatile Chelator Platform for Technetium-99m and Rhenium-188 Radiolabeling of Biomolecules

Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair

Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticals

Chelator-free synthesis of a dual-modality PET/MRI agent

Palladium(II)-Mediated C-H Tritiation of Complex Pharmaceuticals

[ 186 Re]Re- and [ 99m Tc]Tc-Tricarbonyl Metal Complexes with 1,4,7-Triazacyclononane-Based Chelators Bearing Amide, Alcohol, or Ketone Pendent Groups

Pt(II)‐Phenanthroline‐Ln(III)‐DOTA d‐f Hybrids as Small‐Molecule Theranostics

Development of Thiacrown Ligands for Encapsulation of Mercury-197m/g into Radiopharmaceuticals

Homogenous Palladium-Catalyzed Dehalogenative Deuteration and Tritiation of Aryl Halides with D2/T2 Gas

Tritiation of aryl thianthrenium salts with a molecular palladium catalyst

Design and Development of New Hydroxy Methyl Phosphine Based Bifunctional Chelating Agents (BFCAs) for Use in Radiopharmaceutical Applications

Azide vs Alkyne Functionalization in Pt(II) Complexes for Post-treatment Click Modification: Solid-State Structure, Fluorescent Labeling, and Cellular Fate

99m Tc-labeled colchicine for tumor imaging using DTPA as bifunctional chelating agent

Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al 18 F/ 68 Ga/ 111 In

NOTA and NODAGA [99mTc]Tc- and [186Re]Re-Tricarbonyl Complexes: Radiochemistry and First Example of a [99mTc]Tc-NODAGA Somatostatin Receptor-Targeting Bioconjugate

Chemoselective Methionine Bioconjugation: Site-Selective Fluorine-18 Labeling of Proteins and Peptides

Synthesis and Photochemical Studies on Gallium and Indium Complexes of DTPA-PEG3-ArN3 for Radiolabeling Antibodies

"Off‐Label" Use of Enterobactin Enables Targeted Imaging of Cancer with Radioactive Ti(IV)

Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging

Chelation in One Fell Swoop: Optimizing Ligands for Smaller Radiometal Ions

Platinum(II)-Metallaclip-Based Theranostics for Cell Imaging and Synergetic Chemotherapy-Photodynamic Therapy